Methyl 3-oxoisoindoline-4-carboxylate

Catalog No. :
ACPEAY401
CAS No. :
935269-25-3
Molecular Formula :
C10H9NO3
Molecular Weight :
191.19

IUPAC Name:methyl 3-oxoisoindoline-4-carboxylate

Methyl 3-oxoisoindoline-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$56.00Login to see priceIn stockInquiry
1g97%$191.00Login to see priceIn stockInquiry
5g97%$850.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-oxoisoindoline-4-carboxylate
IUPAC Namemethyl 3-oxoisoindoline-4-carboxylate
MDL No.MFCD11506113
Molecular FormulaC10H9NO3
Molecular Weight191.19
SMILESO=C(C1=CC=CC(CN2)=C1C2=O)OC
InChI KeyXWWXOIXNLPEQDH-UHFFFAOYSA-N
Synonym2,3-Dihydro-3-oxo-1H-isoindole-4-carboxylic acid methyl ester | BDBM50264658 | F13612 | SCHEMBL5333318 | Methyl 3-oxo-2,3-dihydro-1H-isoindole-4-carboxylate | BS-49507 | methyl 3-oxoisoindoline-4-carboxylate | methyl 3-oxo-1,2-dihydroisoindole-4-carboxyla
CAS No.935269-25-3
PubChem CID44579993

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPEAY401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPEAY401 route product structure diagram
    ACPEAY401935269-25-3 In Stock
Inquiry

2. ACPEAY401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACCDGE579 route compound structure diagram
    ACCDGE579935269-27-5 In Stock
  4. Then
  5. ACPEAY401 route product structure diagram
    ACPEAY401935269-25-3 In Stock
Inquiry

Comments (0)